Citius Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
August 14, 2023 at 04:07 pm EDT
Citius Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended June 30, 2023. For the third quarter, the company reported net loss was USD 8.48 million compared to USD 8.86 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.06 a year ago.
For the nine months, net loss was USD 22.6 million compared to USD 25.65 million a year ago. Basic loss per share from continuing operations was USD 0.15 compared to USD 0.18 a year ago.